Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Martin A. Mück-Häusl"'
Autor:
Benjamin J. Burwitz, Jochen M. Wettengel, Martin A. Mück-Häusl, Marc Ringelhan, Chunkyu Ko, Marvin M. Festag, Katherine B. Hammond, Mina Northrup, Benjamin N. Bimber, Thomas Jacob, Jason S. Reed, Reed Norris, Byung Park, Sven Moller-Tank, Knud Esser, Justin M. Greene, Helen L. Wu, Shaheed Abdulhaqq, Gabriela Webb, William F. Sutton, Alex Klug, Tonya Swanson, Alfred W. Legasse, Tania Q. Vu, Aravind Asokan, Nancy L. Haigwood, Ulrike Protzer, Jonah B. Sacha
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
Hepatitis B virus (HBV) has a limited host range and current animal models can only recapitulate certain aspects of HBV replication. Here, the authors show that expression of the HBV receptor NTCP in macaques supports HBV replication in vivo, suggest
Externí odkaz:
https://doaj.org/article/2039d96647514d3c9a3deb587404ab5a
Autor:
Martin A. Mück-Häusl, Ulrike Protzer, Simon P. Fräßle, Karin Wisskirchen, Dirk H. Busch, Marvin M. Festag, Julia Festag, Julia Sacherl, Theresa Asen, Sophia Schreiber
Publikováno v:
Mol. Ther. 27, 947-959 (2019)
Mol Ther
Mol Ther
Chimeric antigen receptor (CAR) T cell therapy is a promising novel therapeutic approach for cancer but also for chronic infection. We have developed a fully human, second-generation CAR directed against the envelope protein of hepatitis B virus on t
Autor:
Shaheed A. Abdulhaqq, Justin M. Greene, Aravind Asokan, Katherine B. Hammond, Jochen M. Wettengel, Gabriela M. Webb, Alfred W. Legasse, William F. Sutton, Jonah B. Sacha, Marc Ringelhan, Marvin M. Festag, Thomas Jacob, Chunkyu Ko, Reed A. Norris, Sven Moller-Tank, Martin A. Mück-Häusl, Tania Q. Vu, Byung Park, Nancy L. Haigwood, Mina Northrup, Alex Klug, Benjamin N. Bimber, Benjamin J. Burwitz, Ulrike Protzer, Tonya Swanson, Knud Esser, Helen L. Wu, Jason S. Reed
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
Nature Communications
Nat. Commun. 8:2146 (2017)
Nature Communications
Nat. Commun. 8:2146 (2017)
Hepatitis B virus (HBV) is a major global health concern, and the development of curative therapeutics is urgently needed. Such efforts are impeded by the lack of a physiologically relevant, pre-clinical animal model of HBV infection. Here, we report
Autor:
Festag, Julia, Festag, Marvin M., Asen, Theresa, Wettengel, Jochen M., Mück-Häusl, Martin A., Abdulhaqq, Shaheed, Stahl-Hennig, Christiane, Sacha, Jonah B., Burwitz, Benjamin J., Protzer, Ulrike, Wisskirchen, Karin
Publikováno v:
Human Gene Therapy; Dec2023, Vol. 34 Issue 23/24, p1204-1218, 15p
Autor:
Theresa Asen, Martin A. Mück-Häusl, Anna D. Kosinska, Julia Festag, Marvin M. Festag, Ulrike Protzer
Publikováno v:
Vaccines
Volume 9
Issue 8
Vaccines 9:841 (2021)
Vaccines, Vol 9, Iss 841, p 841 (2021)
Volume 9
Issue 8
Vaccines 9:841 (2021)
Vaccines, Vol 9, Iss 841, p 841 (2021)
During the natural course of chronic hepatitis B virus (HBV) infection, the hepatitis B e antigen (HBeAg) is typically lost, while the direct transmission of HBeAg-negative HBV may result in fulminant hepatitis B. While the induction of HBV-specific
Autor:
Burwitz, Benjamin J., Wettengel, Jochen M., Mück-Häusl, Martin A., Ringelhan, Marc, Ko, Chunkyu, Festag, Marvin M., Hammond, Katherine B., Northrup, Mina, Bimber, Benjamin N., Jacob, Thomas, Reed, Jason S., Norris, Reed, Park, Byung, Moller-Tank, Sven, Esser, Knud, Greene, Justin M., Wu, Helen L., Abdulhaqq, Shaheed, Webb, Gabriela, Sutton, William F.
Publikováno v:
Nature Communications; 12/15/2017, Vol. 8 Issue 1, p1-10, 10p